Profile data is unavailable for this security.
About the company
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
- Revenue in GBP (TTM)30.80m
- Net income in GBP-21.70m
- Incorporated2016
- Employees287.00
- LocationCreo Medical Group PLCUnit 2 Beaufort Park,, Beaufort Park WayCHEPSTOW NP16 5UHUnited KingdomGBR
- Phone+44 129 160 6005
- Websitehttps://creomedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carmat SA | 2.38m | -45.87m | 92.42m | 182.00 | -- | -- | -- | 38.81 | -2.18 | -2.18 | 0.1128 | -1.09 | 0.0405 | 1.63 | 0.6353 | 15,368.13 | -77.90 | -76.92 | -97.48 | -94.38 | -1,109.12 | -- | -1,925.92 | -4,636.64 | 1.19 | -17.09 | 1.88 | -- | 710.72 | -- | -0.3502 | -- | 16.99 | -- |
| Meditera Tibbi Mlzm Sny Tcrt AS | 35.22m | 627.35k | 93.80m | 728.00 | 149.52 | 2.59 | 48.67 | 2.66 | 0.2174 | 0.2174 | 12.20 | 12.53 | 0.7678 | 2.92 | 5.31 | 1,994,873.00 | 1.37 | 9.37 | 1.59 | 11.54 | 44.33 | 43.51 | 1.78 | 9.85 | 2.83 | -- | 0.0552 | 181.79 | -8.99 | 48.75 | -77.38 | 15.68 | -- | -- |
| Mercator Medical SA | 93.25m | -3.91m | 97.36m | 961.00 | -- | 0.5213 | -- | 1.04 | -1.03 | -1.03 | 56.73 | 88.23 | 0.458 | 2.63 | 7.06 | 488,099.90 | -2.23 | 24.69 | -2.39 | 29.07 | 2.41 | 36.99 | -4.87 | 22.78 | 5.57 | -- | 0.0063 | -- | -13.54 | 2.21 | 89.62 | -- | -1.93 | -- |
| Optomed Oyj | 12.73m | -3.72m | 112.23m | 114.00 | -- | 6.72 | -- | 8.82 | -0.2575 | -0.2575 | 0.8872 | 1.08 | 0.5199 | 1.70 | 3.94 | 131,131.60 | -15.21 | -12.95 | -18.59 | -15.90 | 66.76 | 65.69 | -29.25 | -27.84 | 1.72 | -12.96 | 0.1894 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
| Amplitude Surgical SA | 88.59m | 36.81m | 119.39m | 416.00 | 3.24 | 1.48 | 2.56 | 1.35 | 0.9002 | 0.9002 | 2.17 | 1.97 | 0.3955 | 0.5652 | 8.83 | 244,244.10 | 16.21 | -0.3658 | 19.44 | -0.4267 | 79.41 | 78.30 | 40.98 | -1.08 | 1.21 | 0.4163 | 0.5395 | -- | 14.44 | -0.0271 | 993.58 | -- | 7.11 | -- |
| C Rad AB | 34.47m | 3.63m | 120.55m | 89.00 | 34.09 | 5.65 | 27.87 | 3.50 | 1.43 | 1.43 | 13.57 | 8.61 | 1.20 | 4.90 | 3.05 | 5,266,839.00 | 12.69 | 5.09 | 17.96 | 7.02 | 45.14 | 43.12 | 10.61 | 4.86 | 2.43 | -- | 0.0058 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
| Pulsion Medical Systems SE | 26.96m | 4.60m | 121.76m | 71.00 | 26.57 | 5.18 | 21.02 | 4.52 | 0.6549 | 0.6549 | 3.84 | 3.36 | 0.9711 | 1.77 | 3.88 | 446,048.40 | 16.58 | 19.82 | 21.24 | 29.72 | 63.66 | 50.42 | 17.07 | 21.57 | 1.77 | 15.74 | 0.00 | -- | 20.69 | 7.87 | -399.21 | -- | -- | 0.00 |
| ADDvise Group AB (publ) | 111.04m | 8.34m | 125.27m | 620.00 | 23.87 | 3.34 | 7.43 | 1.13 | 0.5864 | 0.5864 | 7.84 | 4.20 | 0.5506 | 6.73 | 5.52 | 2,365,224.00 | 4.14 | 3.72 | 5.17 | 4.77 | 47.63 | 48.95 | 7.51 | 5.89 | 1.09 | 2.99 | 0.6608 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| Creo Medical Group PLC | 30.80m | -21.70m | 131.94m | 287.00 | -- | 2.20 | -- | 4.28 | -0.0709 | -0.0709 | 0.0984 | 0.1655 | 0.4054 | 1.78 | 4.01 | 107,317.10 | -28.56 | -26.07 | -34.84 | -30.94 | 49.68 | 47.58 | -70.45 | -118.24 | 3.01 | -- | 0.1219 | -- | 13.36 | -- | 19.44 | -- | -- | -- |
| Bastide Le Confort Medical SA | 445.58m | 5.38m | 135.23m | 3.55k | 29.59 | 1.96 | 1.93 | 0.3035 | 0.7299 | 0.772 | 65.57 | 11.02 | 0.7955 | 5.44 | 6.90 | 147,580.70 | 1.84 | 2.49 | 2.66 | 3.52 | 50.54 | 48.82 | 2.31 | 3.05 | 0.811 | 1.92 | 0.8391 | -- | 8.48 | 11.94 | 11.24 | 17.55 | 6.98 | -- |
| Stille AB | 27.25m | 2.68m | 135.88m | 142.00 | 33.49 | 2.80 | 33.86 | 4.99 | 6.00 | 6.00 | 60.20 | 71.84 | 0.5364 | 1.77 | 7.18 | 3,416,557.00 | 5.27 | 7.03 | 6.35 | 8.19 | 46.76 | 43.93 | 9.82 | 9.85 | 0.9879 | 7.17 | 0.00 | 21.98 | 19.70 | 16.78 | -2.48 | 5.34 | 23.62 | -- |
| Prim SA | 184.35m | 10.79m | 149.41m | 900.00 | 13.83 | 1.39 | 7.73 | 0.8105 | 0.745 | 0.745 | 12.73 | 7.40 | 1.12 | 1.99 | 4.10 | 240,567.40 | 6.58 | 6.68 | 9.24 | 8.90 | 37.93 | 38.11 | 5.85 | 6.43 | 1.22 | -- | 0.1681 | -- | 9.77 | 10.00 | 51.02 | -2.14 | 12.86 | -- |
| Onward Medical NV | 0.00 | -30.81m | 160.99m | 99.00 | -- | 9.19 | -- | -- | -1.20 | -1.20 | 0.00 | 0.594 | 0.00 | -- | -- | 0.00 | -60.19 | -55.70 | -68.71 | -61.60 | -- | -- | -- | -79,513.95 | -- | -58.04 | 0.4848 | -- | -34.62 | -- | -10.40 | -- | 32.59 | -- |
| Bactiguard Holding AB | 16.61m | -9.49m | 164.89m | 191.00 | -- | 7.20 | -- | 9.93 | -3.60 | -3.60 | 6.30 | 9.80 | 0.3035 | 4.28 | 6.00 | 1,017,544.00 | -17.35 | -7.56 | -19.82 | -8.81 | 29.87 | 47.91 | -57.15 | -26.28 | 1.64 | -11.90 | 0.4129 | -- | -11.96 | 6.46 | -161.71 | -- | 8.43 | -- |
Data as of Jun 06 2024. Currency figures normalised to Creo Medical Group PLC's reporting currency: UK Pound GBX
40.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Canaccord Genuity Wealth Ltd.as of 19 Mar 2024 | 39.30m | 10.87% |
| M&G Investment Management Ltd.as of 31 Jan 2024 | 33.53m | 9.28% |
| Amati Global Investors Ltd.as of 31 Jan 2024 | 15.71m | 4.35% |
| Baillie Gifford & Co.as of 31 Dec 2022 | 12.54m | 3.47% |
| BlackRock Investment Management (UK) Ltd.as of 30 May 2024 | 10.79m | 2.98% |
| SVM Asset Management Ltd.as of 30 Jun 2023 | 10.62m | 2.94% |
| AXA Investment Managers UK Ltd.as of 31 Dec 2022 | 7.99m | 2.21% |
| Chelverton Asset Management Ltd.as of 30 Jun 2023 | 7.50m | 2.08% |
| Tellworth Investments LLPas of 31 Dec 2022 | 5.77m | 1.60% |
| Octopus Investments Ltd.as of 30 Apr 2024 | 3.70m | 1.02% |
More ▼
Data from 30 Sep 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
